Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV002293090 | SCV002585984 | likely pathogenic | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | TREX1: PVS1:Strong, PM2 |
3billion | RCV003152792 | SCV003841774 | likely pathogenic | Aicardi-Goutieres syndrome 1 | 2023-02-23 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. This variant was predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10%. Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. |